TABLE 1:

Clinical characteristics, neuropsychiatric symptoms, and radiologic abnormalities of 11 patients with a history of NPSLE

Patient No./Age/SexMR Imaging AbnormalitiesMean WML size, mmNP Symptoms and Time Since Occurrence*
1/47 y/F2 WMLs5 ±0Cerebrovascular disease, 3 mo
2/6 mo/FSmall cerebellar infarction, cerebral atrophy, 2 WMLs6 ± 1.4Primary generalized tonic-clonic seizures, 6 mo
3/41 y/F7 WMLs3.7 ± 2.0Movement disorder, 18 mo
4/25 y/F6 WMLs, cerebral atrophy3.7 ± 1.0Absence seizures, 10 mo
5/27 y/FNo WMLNACerebrovascular disease, 10 mo
6/36 y/FNo WMLNACerebrovascular Disease, 6 mo
7/49 y/F21 WML3.0 ± 1.1Cranial neuropathy, 2 mo
8/32 y/FCerebral trophy, 29 WMLs6.3 ± 3.9Cerebrovascular disease, cognitive dysfunction, 5 mo
9/26 y/FNo WMLNAAcute confusional state, 10 mo
10/24 y/FSmall venous angioma, left frontalNAAbsence seizures, 7 mo
11/39 y/FNo WMLNAHeadache from intracranial hypertension, 5 mo
  • Note.—WML indicates white matter lesion.

  • * According to the American College of Rheumatology nomenclature and case definitions for NPSLE.

  • No infarctions present on MR images obtained at the time of manifestation.